Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Gross Profit (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Gross Profit readings, the most recent being $8160.0 for Q1 2026.

  • On a quarterly basis, Gross Profit rose 282.75% to $8160.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $97394.0, a 67.37% decrease, with the full-year FY2025 number at $262916.0, up 29.36% from a year prior.
  • Gross Profit reached $8160.0 in Q1 2026 per CBIH's latest filing, down from $42766.0 in the prior quarter.
  • The five-year high for Gross Profit was $170525.0 in Q3 2024, with the low at -$4465.0 in Q1 2025.
  • A 5-year average of $47583.6 and a median of $36588.5 in 2025 define the central range for Gross Profit.
  • Year-over-year, Gross Profit tumbled 118.15% in 2025 and then soared 282.75% in 2026.
  • Year by year, Gross Profit stood at $75491.0 in 2022, then crashed by 35.55% to $48656.0 in 2023, then soared by 36.56% to $66445.0 in 2024, then plummeted by 35.64% to $42766.0 in 2025, then plummeted by 80.92% to $8160.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Gross Profit are $8160.0 (Q1 2026), $42766.0 (Q4 2025), and $16057.0 (Q3 2025).